Xu, Chen <br/><br/>
Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type.  [electronic resource] 

 -  Oncotarget  May 2017 
 - 33185-33196 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.16567  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Biomarkers, Tumor<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Staging<br/>Receptor, ErbB-2--metabolism<br/>Stomach Neoplasms--drug therapy<br/>Survival Analysis<br/>Trastuzumab--administration & dosage<br/>Treatment Failure<br/>Treatment Outcome